Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
National Institutes of Health awards grant to MSU professors for research on neurodegenerative disease

National Institutes of Health awards grant to MSU professors for research on neurodegenerative disease

A research collaboration between three Montana State University faculty members recently received a grant to help fund their study on the connection between a rare genetic neurological disease and metabolism, the human gut microbiome and degeneration of the nervous system. The work could further the understanding of what causes more common neurodegenerative diseases and eventually pave the way for therapeutics to treat them.

The National Institutes of Health awarded $2.9 million to MSU professors Frances Lefcort, Seth Walk and Valerie Copié for their research into Familial dysautonomia, a disease that attacks and devastates the nervous system. The five-year grant will fund their research and student education, including the several undergraduates and two graduate students who are currently contributing research to the project.

Lefcort’s lab has researched Familial dysautonomia, a disease that runs in her family, for eight years. She explained that the disease begins in utero, where parts of the nervous system don’t develop properly. It grows progressively worse over the years as nerve cells die.

While rare, the genetic mutation that causes Familial dysautonomia has been identified, which makes it a useful model for research into other neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, said Lefcort, who is the Letters and Science Distinguished Professor in MSU’s Department of Cell Biology and Neuroscience.

She said one common problem among people with Familial dysautonomia is that they are very thin and have trouble putting on weight, which would suggest a metabolic problem. Another is that the gastrointestinal tract doesn’t function normally, which leads to diarrhea, constipation, esophageal reflux or other gastrointestinal issues.

Lefcort sought out experts in both of those research areas from among her MSU colleagues: Walk’s expertise is in gut microbiomes, and Copié studies metabolism. She learned that the nervous system is closely involved with the human gut microbiome and is affected by metabolism.

“There are more than 100 million neurons just in your gut, and it’s well known that there’s extensive communication between the brain and the gut through the gut-brain axis,” Lefcort said.

Realizing the likely connection between their research, the interdisciplinary trio collaborated to further study the roles of the gut microbiome, nervous system and metabolism (also called “metabolome”) in Familial dysautonomia. Using Walk’s specially bred, germ-free laboratory mice as models, the scientists hope to selectively manipulate “each leg of the triangle to determine how these systems affect each other and contribute to neurodegenerative disease,” Lefcort said.

“Nothing like this has ever been done in this disease, and it’s only starting to be done in major disease like Alzheimer’s and Parkinson’s,” Lefcort said. “We feel that work from this grant will not only inform our understanding of Familial dysautonomia, but also provide a great model for understanding how the gut microbiome, metabolome and nervous system are interacting in these major neurogenerative diseases.”

The trio has already gathered promising preliminary data through a collaboration with New York University’s Dysautonomia Center, which sees all North American patients with Familial dysautonomia.

“They have sent us stool and blood samples from their patients and their patients’ relatives, and we’ve already shown that the microbiome of those patients is significantly different from that of their relatives,” Lefcort said. “We have good data suggesting we have something here, and now using our mouse models, we can really tease apart the causality — is there a metabolic problem that’s affecting the microbiome, and/or is it the microbiome that’s altering metabolism and contributing to the neurodegeneration?”

Lefcort will analyze the nervous system in the gastrointestinal tracts of the laboratory mice, seeking answers to questions such as whether altering the metabolism or microbiome helps prevent neurodegeneration.

Walk will direct the microbiome-focused aspects of the project, which will include a detailed investigation of bacteria living in the intestines of patients who have neurodegenerative disease. He will also lead research focused on the microbiome and whether bacteria in the gut produce compounds that trigger neurons to grow or to die. He’ll do this using cutting-edge DNA sequencing coupled with germ-free and gnotobiotic mice.

“Germ-free mice are completely sterile and do not have any microorganisms living inside them or on them. These animals help us understand what aspects of our ‘health’ are missing when microbes are not around,” said Walk, an associate professor in MSU’s Department of Microbiology and Immunology in the College of Agriculture and the College of Letters and Science. “Gnotobiotic mice have a defined microbiome, whereby we can discover the specific benefits of a particular microbial community.”

Copié, a professor in MSU’s Department of Chemistry and Biochemistry and director of the Nuclear Magnetic Resonance Center, will lead the effort to identify the metabolic processes that are impaired by Familial dysautonomia and how those impairments in energy production affect the gut-brain axis and contribute to neurodegeneration.

“Our lab will be responsible for undertaking the global profiling and characterization of small molecule metabolites present in stool and serum samples of Familial dysautonomia patients and animal models,” Copié said. “These studies will integrate nuclear magnetic spectroscopy and mass spectrometry techniques to identify the metabolic changes that take place in Familial dysautonomia. Our goal is to explore whether we can redress the metabolic deficits observed in Familial dysautonomia via microbiome intervention and whether restoring healthy metabolomes can help or either slow down neurodegeneration or help restore neuronal health.”

The high-resolution metabolic data generated by the NMR Center will contribute to the field of biomedical research and “will help us better understand how the metabolome, microbiome and neuronal circuitry interact together and can lead to irreversible neurodegeneration when impaired,” Copié said.

“It’s clear that the triggers are different for Parkinson’s, Alzheimer’s and ALS, but they all converge on common downstream pathways,” Lefcort said. “We have shown that Familial dysautonomia converges on the same pathways. Now, we’re trying to find out if we can intervene at these common points.

“Whatever we discover here is going to be applicable to the major neurodegenerative disorders,” she said.

Tagged with:

About author

Related Articles